Cellectis S.A.
Cellectis S.A., a pioneering biotechnology company headquartered in France, is at the forefront of gene-editing technology. Founded in 1999, Cellectis has established itself as a leader in the development of innovative CAR-T cell therapies, focusing on treating various cancers and genetic disorders. With a strong presence in Europe and North America, the company leverages its proprietary TALEN® technology to create unique, targeted gene-editing solutions. Cellectis' core offerings include allogeneic CAR-T therapies, which are designed to enhance the efficacy and safety of cancer treatments. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and advancements in clinical trials, solidifying its position in the competitive biotech landscape. With a commitment to transforming patient care, Cellectis continues to push the boundaries of genetic engineering and cellular therapies.
DitchCarbon Score
How does Cellectis S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cellectis S.A.'s score of 26 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cellectis S.A.'s reported carbon emissions
Cellectis S.A., headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures for the most recent year. Consequently, there are no recorded emissions in terms of Scope 1, 2, or 3. Additionally, the company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As there is no available data on emissions or climate commitments, it is unclear how Cellectis S.A. is addressing its environmental impact. The lack of information may suggest that the company is in the early stages of developing its climate strategy or reporting framework.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cellectis S.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
